Ip Clinic Sp. Z O. O.
Lodz 90-752
2 studies enrolling now · 10 studies all time
What they study most
Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC), Asthma, Atopic Dermatitis, Breast Neoplasms, Crohn Disease, Crohn's Disease, Prurigo Nodularis, Ulcerative Colitis, Ulcerative Colitis Chronic
Studies at this site
- ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer — Recruiting now
- A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis — Recruiting now
- A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD) — Completed
- A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
- A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) — Stopped early
- An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
- A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease — Stopped early
- Phase 2 Study to Evaluate RPT193 in Adults With Moderate to Severe T2-high Asthma — Stopped early
- Study of Eftilagimod Alfa (Efti) in Combination With Pembrolizumab and Chemotherapy Versus Placebo in Combination With Pembrolizumab and Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) (TACTI-004) — Running, not enrolling
- A Study of CDX-0159 in Patients With Prurigo Nodularis — Completed